Cargando…
Lipidated Dengue-2 Envelope Protein Domain III Independently Stimulates Long-Lasting Neutralizing Antibodies and Reduces the Risk of Antibody-Dependent Enhancement
BACKGROUND: Dengue virus is a mosquito-transmitted virus that can cause self-limiting dengue fever, severe life-threatening dengue hemorrhagic fever and dengue shock syndrome. The existence of four serotypes of dengue virus has complicated the development of an effective and safe dengue vaccine. Rec...
Autores principales: | Chiang, Chen-Yi, Pan, Chien-Hsiung, Hsieh, Chun-Hsiang, Tsai, Jy-Ping, Chen, Mei-Yu, Liu, Hsueh-Hung, Liu, Shih-Jen, Chong, Pele, Leng, Chih-Hsiang, Chen, Hsin-Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3777875/ https://www.ncbi.nlm.nih.gov/pubmed/24069487 http://dx.doi.org/10.1371/journal.pntd.0002432 |
Ejemplares similares
-
Immunogenicity of a novel tetravalent vaccine formulation with four recombinant lipidated dengue envelope protein domain IIIs in mice
por: Chiang, Chen-Yi, et al.
Publicado: (2016) -
Dengue-1 Envelope Protein Domain III along with PELC and CpG Oligodeoxynucleotides Synergistically Enhances Immune Responses
por: Chiang, Chen-Yi, et al.
Publicado: (2012) -
A Novel Single-Dose Dengue Subunit Vaccine Induces Memory Immune Responses
por: Chiang, Chen-Yi, et al.
Publicado: (2011) -
The Immunodominance Change and Protection of CD4(+) T-Cell Responses Elicited by an Envelope Protein Domain III-Based Tetravalent Dengue Vaccine in Mice
por: Chen, Hsin-Wei, et al.
Publicado: (2015) -
Recombinant lipidated Zika virus envelope protein domain III elicits durable neutralizing antibody responses against Zika virus in mice
por: Chen, Mei-Yu, et al.
Publicado: (2020)